Tseng Yu-Ting, Harroun Scott G, Wu Chien-Wei, Mao Ju-Yi, Chang Huan-Tsung, Huang Chih-Ching
Department of Chemistry, National Taiwan University, Taipei 10617, Taiwan.
Department of Chemistry, Université de Montréal, Montréal, Québec H3C 3J7, Canada.
Nanotheranostics. 2017 Mar 30;1(2):141-153. doi: 10.7150/ntno.18897. eCollection 2017.
We have developed a simple, rapid, high-throughput cancer diagnosis system using functional nanoparticles (NPs) consisting of poly(catechin) capped-gold NPs (Au@PC NPs) and smaller nucleolin-binding aptamer (AS1411) conjugated gold NPs (AS1411-Au NPs). The AS1411-Au NPs/Au@PC NP is used as a targeting agent in laser desorption/ionization mass spectrometry (LDI-MS)-based tumor tissue imaging. Self-assembled core-shell Au@PC NPs are synthesized by a simple reaction of tetrachloroaurate(III) with catechin. Au@PC NPs with a well-defined and dense poly(catechin) shell (40-60 nm) on the surface of each Au core (60-80 nm) are obtained through careful control of the ratio of catechin to gold ions, as well as the pH of the reaction solution. Furthermore, we have shown that AS1411-conjugated Au NPs (13-nm) self-assembled on Au@PC NP can from a satellite-like gold nanocomposite. The high density of AS1411-Au NPs on the surface of Au@PC NP enhances multivalent binding with nucleolin molecules on tumor cell membranes. We have employed LDI-MS to detect AS1411-Au NPs/Au@PC NPs labeled nucleolin-overexpressing MCF-7 breast cancer cells through the monitoring of Au cluster ions ([Au ]; 1 ≤ ≤ 3). The ultrahigh signal amplification from Au NPs through the formation of a huge number of [Au ] ions results in a sensing platform with a limit of detection of 100 MCF-7 cells mL. Further, we have applied the satellite-like AS1411-Au NPs/Au@PC NP nanocomposite as a labeling agent for tumor tissue imaging by LDI-MS. Our nanocomposite-assisted LDI-MS imaging platform can be extended for simultaneous analysis of different tumor markers on cell membranes when using different ligand-modified metal nanoparticles.
我们开发了一种简单、快速、高通量的癌症诊断系统,该系统使用功能性纳米颗粒(NPs),其由聚(儿茶素)包覆的金纳米颗粒(Au@PC NPs)和较小的与核仁素结合的适体(AS1411)共轭金纳米颗粒(AS1411-Au NPs)组成。AS1411-Au NPs/Au@PC NP用作基于激光解吸/电离质谱(LDI-MS)的肿瘤组织成像中的靶向剂。通过四氯金酸(III)与儿茶素的简单反应合成自组装核壳Au@PC NPs。通过仔细控制儿茶素与金离子的比例以及反应溶液的pH值,可在每个金核(60-80 nm)表面获得具有明确且致密的聚(儿茶素)壳(40-60 nm)的Au@PC NPs。此外,我们已经表明,在Au@PC NP上自组装的AS1411共轭金纳米颗粒(13 nm)可以形成卫星状金纳米复合材料。Au@PC NP表面上高密度的AS1411-Au NPs增强了与肿瘤细胞膜上核仁素分子的多价结合。我们采用LDI-MS通过监测金簇离子([Au ]; 1 ≤ ≤ 3)来检测AS1411-Au NPs/Au@PC NPs标记的核仁素过表达的MCF-7乳腺癌细胞。通过形成大量的[Au ]离子,金纳米颗粒产生的超高信号放大导致了一个检测限为100个MCF-7细胞/mL的传感平台。此外,我们已将卫星状AS1411-Au NPs/Au@PC NP纳米复合材料用作LDI-MS肿瘤组织成像的标记剂。当使用不同配体修饰的金属纳米颗粒时,我们的纳米复合材料辅助LDI-MS成像平台可扩展用于同时分析细胞膜上的不同肿瘤标志物。